Clinical Outcomes Of A New Full Range Of Vision Iol With An Innovative Spiral Optic
Published 2025 - 43rd Congress of the ESCRS
Reference: PO397 | Type: Free paper | DOI: 10.82333/gx2v-af27
Authors: Laura Mariñas Garcia* 1 , Laureano Alvarez-Rementeria Capelo 1 , Javier Ruiz Alcocer 2
1Rementeria Clinic,Madrid,Spain, 2Universidad Complutense de Madrid,Madrid,Spain
Purpose
The purpose of this retrospective case study was to evaluate the clinical outcomes of patients implanted with a new full range of vision IOL with a novel spiral optic.
Setting
Freedom Vision. Private cataract hospital in Leeds, UK.
Methods
A retrospective study was carried out to assess the visual outcomes of the first 20 consecutive eyes of 11 patients implanted with either RayOne Galaxy (RAO605G) or RayOne Galaxy Toric (RAO615X) IOL. Measured parameters at one month post-op included: manifest refraction giving manifest refraction spherical equivalent (MRSE), monocular and binocular uncorrected distance visual acuity (UDVA) , monocular and binocular intermediate visual acuity (UIVA), monocular and binocular near visual acuity (UNVA) and monocular and binocular corrected distance visual acuity (DVA). Subjective symptoms of halo/glare were also recorded.
Results
15 out of 20 eyes (75%) were within +/-0.25D of refractive target, 90% within +/- 0.50D and 100% within +/- 1.00D at one month post-op. Monocularly 85% of eyes achieved UDVA of logMAR 0.00 or better, 90% achieved UIVA of logMAR 0.00 or better and 95% achieved UNVA of logMAR of 0.40 or better. Binocularly 100% achieved UDVA of 0.00 or better, 100% achieved UIVA of 0.00 or better and 100% achieved UNVA of 0.20 or better. One patient (one eye) reported dysphotopsia caused by post-op corneal oedema. No other patients reported haloes or glare due to the IOL. The 2 monocular patients achieved binocular UDVA of 0.00, UIVA of 0.00 and UNVA of 0.18 and were happy with their vision overall.
Conclusions
These results show that the new RayOne Galaxy gives very predictable refractive results. Visual outcomes are also encouraging with patients exhibiting a full range of vision and reporting minimal dysphotopsia Interestingly, when Galaxy was implanted monocularly patients experienced the same binocular level of vision as patients that were implanted binocularly - which opens up the opportunity to successfully treat more people using this novel new full range of vision IOL. ,